BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 1884379)

  • 1. Chemical and physical carcinogenesis: advances and perspectives for the 1990s.
    Harris CC
    Cancer Res; 1991 Sep; 51(18 Suppl):5023s-5044s. PubMed ID: 1884379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
    Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
    IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alteration of genomic structure and/or expression of cancer associated genes in hepatocellular carcinoma].
    Fujimoto Y; Kohgo Y
    Rinsho Byori; 1998 Jan; 46(1):9-14. PubMed ID: 9492532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of multistage carcinogenesis.
    Harris CC
    Princess Takamatsu Symp; 1991; 22():3-19. PubMed ID: 1844248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanisms of chemically induced carcinogenesis].
    Palut D; Kostka G; Adamczyk M
    Rocz Panstw Zakl Hig; 1998; 49(1):35-54. PubMed ID: 9734231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis.
    Soussi T; Dehouche K; Béroud C
    Hum Mutat; 2000; 15(1):105-13. PubMed ID: 10612830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
    Pascale RM; Simile MM; Feo F
    Anticancer Res; 1993; 13(5A):1341-56. PubMed ID: 8239505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.
    Hussain SP; Harris CC
    Mutat Res; 1999 Jul; 428(1-2):23-32. PubMed ID: 10517975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations and DNA repair in human carcinogenesis.
    Dixon K; Kopras E
    Semin Cancer Biol; 2004 Dec; 14(6):441-8. PubMed ID: 15489137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of human carcinogens.
    Barrett JC; Shelby MD
    Prog Clin Biol Res; 1992; 374():415-34. PubMed ID: 1620716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
    Bignold LP
    Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited factors and environmental exposures in cancer risk.
    Shields PG
    J Occup Med; 1993 Jan; 35(1):34-41. PubMed ID: 8423501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinogenesis: from epidemiology to molecular biology].
    Tubiana M
    Bull Acad Natl Med; 1998; 182(1):19-29; discussion 29-31. PubMed ID: 9622929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
    Olshan AF; Weissler MC; Pei H; Conway K
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and lung cancer.
    Brambilla E; Brambilla C
    Pathol Biol (Paris); 1997 Dec; 45(10):852-63. PubMed ID: 9769949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.